Tumour volume was monitored throughout the growth period and consistent with our endpoint results, these data showed that Staufen1-shRNA expressing ERMS and ARMS tumours had decreased tumour volumes (Fig. 6d). The gene discussed is KIDINS220; the disease is neoplasm.